Disclosure Plus

Exchange: "Trading in DASAN DMC Shares Suspended"

KIM YOON-JEONG
2026-08-28 16:42:54
[E-Daily Reporter KIM YOON-JEONG ] The KOSDAQ Market Division of the Korea Exchange announced on the 28th that it will suspend trading of EnGIS Technologies, Inc.(208860)shares starting September 2.
The suspension is due to changes and cancellations in electronic registration resulting from a stock consolidation.
The suspension will remain in effect until the day before the new shares are relisted.

Economy

Corporation

IT·Science

Economy

[Market In] “Unlocking 134.1 Billion in Dormant Assets”… DaelimTrading’s ‘Complete Transformation’ for the First Time in 56 Years

Lee Sang-won, CEO of Daelim Trading ( DaelimTrading(006570) ), announced his ambition to significantly improve the company’s financial structure and revitalize its core business by realizing the value…
2026-09-10 04:52:04
[Market In] In Line with Government Policy, the Venture Ecosystem Is Also Focusing on “Region-Specific” Sectors
2026-09-09 19:57:03
Countdown to Mandatory Tender Offers… Will the Calculations for PEF Acquisitions of Listed Companies Change? [Market In]
2026-09-09 18:25:07

Corporation

"Stable Supply and Quality Despite Heat Waves and Heavy Rains"... Large Supermarkets See Smart Farm Procurement Jump Ninefold

As extreme weather events—such as heat waves exceeding 40 degrees, torrential rains, and typhoons—become the norm, smart farms are rapidly making inroads into the fresh food supply chains of the retai…
2026-09-10 05:50:05
HITEJINRO Ceases Production at Iksan Plant… Operations Consolidated at Jeonju Plant
2026-09-09 15:10:44
APR to Merge with Its Manufacturing Subsidiary, 'APR Factory'
2026-09-09 10:56:04

IT·Science

Galaxy Z8 Sales Up 8% in First Two Weeks… Fold 8 Drives Success

SamsungElectronics(005930) Samsung Electronics’ new foldable smartphone, the “Galaxy Z8” series, recorded higher sales than its predecessor in the early days of its launch. The Galaxy Z Fold8 accounte…
2026-09-09 18:06:05
AriBio U.S. Branch Manager: “Top-line Results for AR1001 Phase 3 Trial to Be Released in November; Approval Application Planned for Q2 Next Year” [K-Bio Deal Summit]
2026-09-09 16:56:02
Hong Seong-hoon, Vice President of D&D: “Targeting the Full Lifecycle with MASH ‘DD01’ and ‘TLY012’” [K-Bio Deal Summit]
2026-09-09 16:51:02